Nuuvera Overview
- Year Founded
-
2015
- Status
-
Acquired/Merged
- Employees
-
35
- Latest Deal Type
-
M&A
- Financing Rounds
-
5
- Investments
-
7
Nuuvera General Information
Description
Producer of medicinal marijuana products. The company is engaged in the testing, formulation, production, extraction and sale of medicinal cannabis products in Canada and other legal International jurisdictions through its subsidiaries.
Contact Information
Website
www.nuuvera.comCorporate Office
- PO Box 20009
- 269 Erie Street South
- Leamington, Ontario N8H 3C4
- Canada
Corporate Office
- PO Box 20009
- 269 Erie Street South
- Leamington, Ontario N8H 3C4
- Canada
Nuuvera Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Nuuvera Comparisons
Industry
Financing
Details
Nuuvera Competitors (1)
One of Nuuvera’s competitors is Tilray Medical Australia New Zealand, a Corporation company based in Sydney, Australia.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Tilray Medical Australia New Zealand | Corporation | Sydney, Australia |
Nuuvera Signals
Nuuvera Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Nuuvera Investments & Acquisitions (7)
Nuuvera’s most recent deal was a Secondary Transaction - Private with Avanti Rx Analytics for . The deal was made on 01-Mar-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Avanti Rx Analytics | 01-Mar-2018 | Secondary Transaction - Private | BPO/Outsource Services | ||
| ASG Pharma | 27-Feb-2018 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology | ||
| Canamo y Fibra Naturales | 24-Jan-2018 | Secondary Transaction - Private | Cultivation | ||
| Medalchemy | 24-Jan-2018 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology | ||
| Tilray Medical Italia | 18-Jan-2018 | Merger/Acquisition | Distributors (Healthcare) |
Nuuvera Exits (3)
Nuuvera’s most recent exit was on 24-Jan-2018 from Canamo y Fibra Naturales. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Canamo y Fibra Naturales | 24-Jan-2018 | Completed |
|
||
| Medalchemy | 24-Jan-2018 | Completed |
|
||
| Tilray Medical Italia | 18-Jan-2018 | Merger/Acquisition | Completed |
Nuuvera FAQs
-
When was Nuuvera founded?
Nuuvera was founded in 2015.
-
Where is Nuuvera headquartered?
Nuuvera is headquartered in Leamington, Canada.
-
What is the size of Nuuvera?
Nuuvera has 35 total employees.
-
What industry is Nuuvera in?
Nuuvera’s primary industry is Drug Delivery.
-
Is Nuuvera a private or public company?
Nuuvera is a Private company.
-
What is the current valuation of Nuuvera?
The current valuation of Nuuvera is .
-
What is Nuuvera’s current revenue?
The current revenue for Nuuvera is .
-
How much funding has Nuuvera raised over time?
Nuuvera has raised $19.5M.
-
Who are Nuuvera’s investors?
Globalive Capital, SEED Innovations (Private Equity), and TSX Inc have invested in Nuuvera.
-
Who are Nuuvera’s competitors?
Tilray Medical Australia New Zealand is a competitor of Nuuvera.
-
When was Nuuvera acquired?
Nuuvera was acquired on 23-Mar-2018.
-
Who acquired Nuuvera?
Nuuvera was acquired by Aphria.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process